English | Español
Erianne Leatherman | Jul 14, 2017

American Cancer Society shares ABCDEs of spotting skin cancer
Erianne Leatherman | Jul 2, 2017

Pfizer’s cardiomyopathy drug, tafamidis, on FDA fast track
Erianne Leatherman | Jul 2, 2017

UC San Diego School of Medicine, Janssen Pharmaceuticals teaming up to research treatments for metabolic diseases
Erianne Leatherman | Jun 29, 2017

AstraZeneca’s Imfinzi gains FDA accelerated approval for bladder cancer patients
Erianne Leatherman | Jun 22, 2017

Chemotherapy can affect breast cancer patients’ gait and balance
Erianne Leatherman | Jun 21, 2017

Lilly says its galcanezumab cuts down on amount of migraine headache days

Erianne Leatherman | Jun 15, 2017

Novartis, IBM Watson join forces to fight breast cancer

Erianne Leatherman | Jun 6, 2017

Novartis highlighting cancer care data at national, international forums

Trending
+ Pharmaceuticals
Patient Daily | Jun 30, 2025

PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+ Pharmaceuticals
Patient Daily | Jun 25, 2025

Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

PhRMA chief public affairs officer on 340B drug pricing: ‘Lowering drug prices for U.S. patients starts by reining in middlemen’